Medibank Private Limited (MPV) - Net Assets
Based on the latest financial reports, Medibank Private Limited (MPV) has net assets worth €2.34 Billion EUR (≈ $2.73 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.70 Billion ≈ $5.50 Billion USD) and total liabilities (€2.36 Billion ≈ $2.76 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MPV financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.34 Billion |
| % of Total Assets | 49.7% |
| Annual Growth Rate | 3.9% |
| 5-Year Change | 22.56% |
| 10-Year Change | N/A |
| Growth Volatility | 4.74 |
Medibank Private Limited - Net Assets Trend (2017–2025)
This chart illustrates how Medibank Private Limited's net assets have evolved over time, based on quarterly financial data. Also explore MPV current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Medibank Private Limited (2017–2025)
The table below shows the annual net assets of Medibank Private Limited from 2017 to 2025. For live valuation and market cap data, see Medibank Private Limited market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €2.34 Billion ≈ $2.73 Billion |
+1.34% |
| 2024-06-30 | €2.31 Billion ≈ $2.69 Billion |
+10.59% |
| 2023-06-30 | €2.08 Billion ≈ $2.44 Billion |
+7.13% |
| 2022-06-30 | €1.95 Billion ≈ $2.27 Billion |
+2.07% |
| 2021-06-30 | €1.91 Billion ≈ $2.23 Billion |
+5.08% |
| 2020-06-30 | €1.81 Billion ≈ $2.12 Billion |
-6.28% |
| 2019-06-30 | €1.94 Billion ≈ $2.26 Billion |
+5.81% |
| 2018-06-30 | €1.83 Billion ≈ $2.14 Billion |
+6.36% |
| 2017-06-30 | €1.72 Billion ≈ $2.01 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Medibank Private Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 38.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €2.22 Billion | 95.19% |
| Other Components | €112.40 Million | 4.81% |
| Total Equity | €2.34 Billion | 100.00% |
Medibank Private Limited Competitors by Market Cap
The table below lists competitors of Medibank Private Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hundsun Technologies Inc
SHG:600570
|
$7.43 Billion |
|
Tripod Technology Corp
TW:3044
|
$7.43 Billion |
|
AAON Inc
NASDAQ:AAON
|
$7.43 Billion |
|
Lifan Industry Group Co Ltd
SHG:601777
|
$7.43 Billion |
|
Brown-Forman Corporation
NYSE:BF-B
|
$7.42 Billion |
|
Sunwoda Electronic
SHE:300207
|
$7.42 Billion |
|
IDACORP Inc
NYSE:IDA
|
$7.41 Billion |
|
EVONIK INDUST.(U.ARD)2
F:EVKA
|
$7.41 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medibank Private Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,305,700,000 to 2,335,900,000, a change of 30,200,000 (1.3%).
- Net income of 500,800,000 contributed positively to equity growth.
- Dividend payments of 480,600,000 reduced retained earnings.
- Share repurchases of 6,400,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €500.80 Million | +21.44% |
| Dividends Paid | €480.60 Million | -20.57% |
| Share Repurchases | €6.40 Million | -0.27% |
| Other Changes | €16.40 Million | +0.7% |
| Total Change | €- | 1.31% |
Book Value vs Market Value Analysis
This analysis compares Medibank Private Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.30x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 4.48x to 3.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | €0.62 | €2.80 | x |
| 2018-06-30 | €0.66 | €2.80 | x |
| 2019-06-30 | €0.70 | €2.80 | x |
| 2020-06-30 | €0.66 | €2.80 | x |
| 2021-06-30 | €0.69 | €2.80 | x |
| 2022-06-30 | €0.71 | €2.80 | x |
| 2023-06-30 | €0.76 | €2.80 | x |
| 2024-06-30 | €0.84 | €2.80 | x |
| 2025-06-30 | €0.85 | €2.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medibank Private Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.44%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.86%
- • Asset Turnover: 1.82x
- • Equity Multiplier: 2.01x
- Recent ROE (21.44%) is below the historical average (22.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 26.14% | 6.49% | 2.00x | 2.01x | €277.52 Million |
| 2018 | 24.33% | 6.35% | 1.98x | 1.94x | €262.18 Million |
| 2019 | 23.70% | 6.79% | 1.86x | 1.88x | €265.16 Million |
| 2020 | 17.37% | 4.65% | 1.80x | 2.07x | €133.61 Million |
| 2021 | 23.15% | 6.29% | 1.79x | 2.06x | €250.59 Million |
| 2022 | 20.25% | 5.55% | 1.56x | 2.34x | €199.34 Million |
| 2023 | 24.52% | 6.82% | 1.71x | 2.11x | €302.66 Million |
| 2024 | 21.36% | 6.14% | 1.71x | 2.03x | €261.93 Million |
| 2025 | 21.44% | 5.86% | 1.82x | 2.01x | €267.21 Million |
Industry Comparison
This section compares Medibank Private Limited's net assets metrics with peer companies in the Insurance - Specialty industry.
Industry Context
- Industry: Insurance - Specialty
- Average net assets among peers: $4,386,929,333
- Average return on equity (ROE) among peers: 11.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medibank Private Limited (MPV) | €2.34 Billion | 26.14% | 1.01x | $7.42 Billion |
| AXIS Capital Holdings Limited (AXV) | $5.03 Billion | 0.86% | 3.80x | $6.88 Billion |
| Assured Guaranty Ltd (DHU) | $5.76 Billion | 12.82% | 1.18x | $3.75 Billion |
| Essent Group Ltd. (EG0) | $2.37 Billion | 19.76% | 0.33x | $5.21 Billion |
About Medibank Private Limited
Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services com… Read more